English
  1. Home
  2. Stocks
  3. Lincoln Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Lincoln Pharmaceuticals Share Price Lincoln Pharmaceuticals

    Small Cap
    ₹565.3
    -5.25 (-0.92%)
    09 May, 2024 12:14 BSE: 531633 NSE: LINCOLNISIN: INE405C01035

    Start SIP in Lincoln Pharmaceuticals

    Start SIP

    Lincoln Pharmaceuticals Performance

    Day Range

    • Low 559
    • High 576
    ₹ 565

    52 Week Range

    • Low 365
    • High 755
    ₹ 565
    • Open Price570
    • Previous Close571
    • Volume18237

    Lincoln Pharmaceuticals Share Price

    • Over 1 Month -7.21%
    • Over 3 Month -14.21%
    • Over 6 Month +0.97%
    • Over 1 Year +47.69%

    Lincoln Pharmaceuticals Key Statistics

    P/E Ratio 13
    PEG Ratio 0.6
    Market Cap Cr 1,132
    Price to Book Ratio 2.3
    EPS 36.2
    Dividend 0.3
    Relative Strength Index 37.02
    Money Flow Index 37.8
    MACD Signal -6.4
    Average True Range 20
    Lincoln Pharmaceuticals Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 146156136112
    Operating Expenses Qtr Cr 11712511596
    Operating Profit Qtr Cr 30312117
    Depreciation Qtr Cr 3332
    Interest Qtr Cr 0001
    Tax Qtr Cr 10964
    Net Profit Qtr Cr 28281913
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 533
    Operating Expenses Annual Cr 421
    Operating Profit Annual in Cr 89
    Depreciation Cr 9
    Interest Annual Cr 2
    Tax Annual Cr 28
    Net Profit Annual Cr 73
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 39
    Cash from Investing Activity Annual Cr -37
    Cash from Financing Annual Activity Cr -5
    Net Cash Flow Annual Cr -2
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 502
    Fixed Assets Annual Cr 157
    Total Non Current Assets Annual Cr 220
    Total Current Assets Annual Cr 367
    Total Assets Annual Cr 587
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 251
    ROE Annual % 15
    ROCE Annual % 20
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 22
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 146156136112
    Operating Expenses Qtr Cr 11712511596
    Operating Profit Qtr Cr 30312117
    Depreciation Qtr Cr 3332
    Interest Qtr Cr 0001
    Tax Qtr Cr 10964
    Net Profit Qtr Cr 28281913
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 533
    Operating Expenses Annual Cr 421
    Operating Profit Annual in Cr 89
    Depreciation Cr 9
    Interest Annual Cr 2
    Tax Annual Cr 28
    Net Profit Annual Cr 73
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 39
    Cash from Investing Activity Annual Cr -37
    Cash from Financing Annual Activity Cr -5
    Net Cash Flow Annual Cr -2
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 502
    Fixed Assets Annual Cr 157
    Total Non Current Assets Annual Cr 220
    Total Current Assets Annual Cr 367
    Total Assets Annual Cr 587
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 251
    ROE Annual % 15
    ROCE Annual % 20
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 22
    Sign Up to Know More
    Invest in Lincoln Pharmaceuticals

    Lincoln Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹565.3
    -5.25 (-0.92%)
    pointer
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 16
    • 20 Day
    • ₹594.13
    • 50 Day
    • ₹608.31
    • 100 Day
    • ₹608.54
    • 200 Day
    • ₹570.51
    • 20 Day
    • ₹593.32
    • 50 Day
    • ₹616.25
    • 100 Day
    • ₹633.02
    • 200 Day
    • ₹576.58

    Lincoln Pharmaceuticals Resistance and Support

    PIVOT
    ₹575.75
    Resistance
    First Resistance 584.75
    Second Resistance 598.95
    Third Resistance 607.95
    RSI 37.02
    MFI 37.80
    MACD Single Line -6.40
    MACD -6.75
    Support
    First Resistance 561.55
    Second Resistance 552.55
    Third Resistance 538.35

    Lincoln Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 37,559 2,433,823 64.8
    Week 35,224 2,026,800 57.54
    1 Month 37,098 2,022,954 54.53
    6 Month 114,201 4,779,331 41.85

    Lincoln Pharmaceuticals Result Highlights

    Lincoln Pharmaceuticals Synopsis

    NSE-Medical-Diversified

    Lincoln Pharmace is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 510.31 Cr. and Equity Capital is Rs. 20.03 Cr. for the Year ended 31/03/2023. Lincoln Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 20/01/1995 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1995PLC024288 and registration number is 024288.
    Market Cap 1,132
    Sales 551
    Shares in Float 1.00
    No of funds 34
    Yield 0.25
    Book Value 2.27
    U/D Vol ratio 0.6
    LTDebt / Equity
    Alpha 0.09
    Beta 0.87

    Lincoln Pharmaceuticals

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 49.53%49.8%50.53%48.67%
    Mutual Funds
    Foreign Portfolio Investors 3.93%3.22%2.59%1.74%
    Individual Investors 37.36%37.78%37.47%37.32%
    Others 9.18%9.2%9.41%12.27%

    Lincoln Pharmaceuticals Management

    Name Designation
    Mr. Kishor M Shah Chairman
    Mr. Mahendra G Patel Managing Director
    Mr. Hashmukh I Patel Whole Time Director
    Mr. Munjal M Patel Whole Time Director
    Mr. Ashish R Patel Whole Time Director
    Mr. Rajnikant G Patel Non Executive Director
    Mr. Meha M Patel Independent Director
    Mr. Saurin J Parikh Independent Director
    Mr. Pirabhai R Suthar Independent Director

    Lincoln Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Lincoln Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-02-08 Quarterly Results
    2023-11-02 Quarterly Results
    2023-08-10 Quarterly Results
    2023-05-25 Audited Results & Dividend
    2023-02-09 Quarterly Results

    Lincoln Pharmaceuticals MF Shareholding

    Name Amount(cr)

    Lincoln Pharmaceuticals FAQs

    What is Share Price of Lincoln Pharmaceuticals ?

    Lincoln Pharmaceuticals share price is ₹565 As on 09 May, 2024 | 12:00

    What is the Market Cap of Lincoln Pharmaceuticals ?

    The Market Cap of Lincoln Pharmaceuticals is ₹1132.3 Cr As on 09 May, 2024 | 12:00

    What is the P/E ratio of Lincoln Pharmaceuticals ?

    The P/E ratio of Lincoln Pharmaceuticals is 13 As on 09 May, 2024 | 12:00

    What is the PB ratio of Lincoln Pharmaceuticals ?

    The PB ratio of Lincoln Pharmaceuticals is 2.3 As on 09 May, 2024 | 12:00

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.